cardiovascular-agents and Postpartum-Hemorrhage

cardiovascular-agents has been researched along with Postpartum-Hemorrhage* in 7 studies

Other Studies

7 other study(ies) available for cardiovascular-agents and Postpartum-Hemorrhage

ArticleYear
Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature.
    Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:6

    Topics: Adult; Cardiomyopathy, Dilated; Cardiovascular Agents; Dinoprostone; Echocardiography; Female; Heart Failure; Humans; Peripartum Period; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome

2013
Algorithm-based coagulation management of catastrophic amniotic fluid embolism.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:1

    Amniotic fluid embolism (AFE) is a rare, but often catastrophic, complication of pregnancy and associated with severe coagulopathy. We present an algorithm-based approach in managing coagulopathy and hemorrhage in a fatal case of histopathologically proven AFE. Thrombelastometry was used for rapid evaluation of the coagulation status. Stop of extensive hyperfibrinolysis with tranexamic acid, stabilization of initial clot formation with high-dose fibrinogen and platelet transfusions, and use of prothrombin complex concentrate together with a 1: 1 transfusion regimen of red packed cells and fresh frozen plasma was successful to control diffuse bleeding and restore clot firmness after hysterectomy. Stable clotting situation was maintained despite further clinical deterioration and development of multiple organ failure in this patient.

    Topics: Acidosis; Adult; Algorithms; Blood Coagulation Factors; Blood Component Transfusion; Cardiovascular Agents; Case Management; Catastrophic Illness; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Embolism, Amniotic Fluid; Fatal Outcome; Female; Fibrinogen; Humans; Hypotension; Hysterectomy; Infant, Newborn; Male; Multiple Organ Failure; Placenta, Retained; Postpartum Hemorrhage; Pregnancy; Sperm Injections, Intracytoplasmic; Thrombelastography; Tranexamic Acid

2010
[Use of gynofort in the prevention and therapy of early postpartum hemorrhage].
    Pediatriia akusherstvo i ginekologiia, 1962, Volume: 1

    Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Hemorrhage; Humans; Oxytocics; Postpartum Hemorrhage; Postpartum Period; Pregnancy

1962
The third stage of labour.
    Postgraduate medical journal, 1961, Volume: 37

    Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Hemorrhage; Humans; Hyaluronoglucosaminidase; Labor, Obstetric; Postpartum Hemorrhage; Postpartum Period; Pregnancy

1961
[Directed methergine administration in prevention of postpartum hemorrhage].
    Munchener medizinische Wochenschrift (1950), 1957, Oct-25, Volume: 99, Issue:43

    Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Hemorrhage; Humans; Labor, Obstetric; Methylergonovine; Oxytocics; Postpartum Hemorrhage; Pregnancy

1957
Use of intravenous ergometrine to prevent postpartum haemorrhage.
    British medical journal, 1953, Mar-21, Volume: 1, Issue:4811

    Topics: Cardiovascular Agents; Ergonovine; Ergot Alkaloids; Female; Hemorrhage; Humans; Oxytocics; Postpartum Hemorrhage; Postpartum Period; Pregnancy

1953
A management of postpartum hemorrhage by prolonged administration of oxytocics.
    American journal of obstetrics and gynecology, 1952, Volume: 64, Issue:5

    Topics: Cardiovascular Agents; Disease Management; Ergot Alkaloids; Female; Hemorrhage; Humans; Oxytocics; Oxytocin; Postpartum Hemorrhage; Postpartum Period; Pregnancy

1952